Skip to main content
Top
Published in: Digestive Diseases and Sciences 2/2018

01-02-2018 | Editorial

Small Intestinal Bacterial Overgrowth and Coronary Artery Disease: What Is in the CArDs?

Authors: Christopher Adkins, Ali Rezaie

Published in: Digestive Diseases and Sciences | Issue 2/2018

Login to get access

Excerpt

Small intestinal bacterial overgrowth (SIBO) manifests with a variety of gastrointestinal symptoms, including bloating, flatulence, abdominal pain, nausea, dyspepsia, fatigue, diarrhea, and constipation [1]. SIBO has been implicated as a cause of hepatic encephalopathy and of d-lactic acidosis in patients with short bowel syndrome [2, 3]. Moreover, SIBO is associated with a variety of conditions outside of the gastrointestinal system, including rosacea [4], restless legs syndrome [5], interstitial cystitis [6], and chronic prostatitis [7], and correlates with the level of somatic pain in fibromyalgia [8]. Along these lines, recent studies have reported a link between SIBO and cardiovascular disease. …
Literature
1.
go back to reference Rezaie A, Pimentel M, Rao SS. How to test and treat small intestinal bacterial overgrowth: an evidence-based approach. Curr Gastroenterol Rep. 2016;18:8.CrossRefPubMed Rezaie A, Pimentel M, Rao SS. How to test and treat small intestinal bacterial overgrowth: an evidence-based approach. Curr Gastroenterol Rep. 2016;18:8.CrossRefPubMed
2.
go back to reference Rai R, Saraswat VA, Dhiman RK. Gut microbiota: its role in hepatic encephalopathy. J Clin Exp Hepatol. 2015;5:S29–S36.CrossRefPubMed Rai R, Saraswat VA, Dhiman RK. Gut microbiota: its role in hepatic encephalopathy. J Clin Exp Hepatol. 2015;5:S29–S36.CrossRefPubMed
3.
go back to reference Bongaerts GP, Tolboom JJ, Naber AH, et al. Role of bacteria in the pathogenesis of short bowel syndrome-associated d-lactic acidemia. Microb Pathog. 1997;22:285–293.CrossRefPubMed Bongaerts GP, Tolboom JJ, Naber AH, et al. Role of bacteria in the pathogenesis of short bowel syndrome-associated d-lactic acidemia. Microb Pathog. 1997;22:285–293.CrossRefPubMed
5.
go back to reference Weinstock LB, Walters AS. Restless legs syndrome is associated with irritable bowel syndrome and small intestinal bacterial overgrowth. Sleep Med. 2011;12:610–613.CrossRefPubMed Weinstock LB, Walters AS. Restless legs syndrome is associated with irritable bowel syndrome and small intestinal bacterial overgrowth. Sleep Med. 2011;12:610–613.CrossRefPubMed
6.
go back to reference Weinstock LB, Klutke CG, Lin HC. Small intestinal bacterial overgrowth in patients with interstitial cystitis and gastrointestinal symptoms. Dig Dis Sci. 2008;53:1246–1251.CrossRefPubMed Weinstock LB, Klutke CG, Lin HC. Small intestinal bacterial overgrowth in patients with interstitial cystitis and gastrointestinal symptoms. Dig Dis Sci. 2008;53:1246–1251.CrossRefPubMed
7.
go back to reference Weinstock LB, Geng B, Brandes SB. Chronic prostatitis and small intestinal bacterial overgrowth: effect of rifaximin. Can J Urol. 2011;18:5826–5830.PubMed Weinstock LB, Geng B, Brandes SB. Chronic prostatitis and small intestinal bacterial overgrowth: effect of rifaximin. Can J Urol. 2011;18:5826–5830.PubMed
8.
go back to reference Pimentel M, Wallace D, Hallegua D, et al. A link between irritable bowel syndrome and fibromyalgia may be related to findings on lactulose breath testing. Ann Rheum Dis. 2004;63:450–452.CrossRefPubMedPubMedCentral Pimentel M, Wallace D, Hallegua D, et al. A link between irritable bowel syndrome and fibromyalgia may be related to findings on lactulose breath testing. Ann Rheum Dis. 2004;63:450–452.CrossRefPubMedPubMedCentral
9.
go back to reference Ponziani FR, Pompili M, Di Stasio E, Zocco MA, Gasbarrini A, Flore R. Subclinical atherosclerosis is linked to small intestinal bacterial overgrowth via vitamin K2-dependent mechanisms. World J Gastroenterol. 2017;23:1241–1249.CrossRefPubMedPubMedCentral Ponziani FR, Pompili M, Di Stasio E, Zocco MA, Gasbarrini A, Flore R. Subclinical atherosclerosis is linked to small intestinal bacterial overgrowth via vitamin K2-dependent mechanisms. World J Gastroenterol. 2017;23:1241–1249.CrossRefPubMedPubMedCentral
10.
go back to reference Giuliano V, Bassotti G, Mourvaki E, et al. Small intestinal bacterial overgrowth and warfarin dose requirement variability. Thromb Res. 2010;126:12–17.CrossRefPubMed Giuliano V, Bassotti G, Mourvaki E, et al. Small intestinal bacterial overgrowth and warfarin dose requirement variability. Thromb Res. 2010;126:12–17.CrossRefPubMed
12.
go back to reference Rezaie A, Buresi M, Lembo A, et al. Hydrogen and methane-based breath testing in gastrointestinal disorders: the North American consensus. Am J Gastroenterol. 2017;112:775–784.CrossRefPubMedPubMedCentral Rezaie A, Buresi M, Lembo A, et al. Hydrogen and methane-based breath testing in gastrointestinal disorders: the North American consensus. Am J Gastroenterol. 2017;112:775–784.CrossRefPubMedPubMedCentral
13.
go back to reference Chang BW, Pimentel M, Chang C, et al. Prevalence of excessive intestinal methane production and its variability with age and gender: a large-scale database analysis. Gastroenterology. 2015;148:S729–S730. Chang BW, Pimentel M, Chang C, et al. Prevalence of excessive intestinal methane production and its variability with age and gender: a large-scale database analysis. Gastroenterology. 2015;148:S729–S730.
Metadata
Title
Small Intestinal Bacterial Overgrowth and Coronary Artery Disease: What Is in the CArDs?
Authors
Christopher Adkins
Ali Rezaie
Publication date
01-02-2018
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 2/2018
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-017-4904-4

Other articles of this Issue 2/2018

Digestive Diseases and Sciences 2/2018 Go to the issue